These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8765979)

  • 1. Evaluation of growth hormone (GH) responses to pulsed GH-releasing hormone administration using the MTT-ESTA bioassay.
    Dattani MT; Winrow AP; Tuil'Pakov A; Pringle PJ; Hindmarsh PC; Brook CG; Marshall NJ
    Eur J Endocrinol; 1996 Jul; 135(1):87-95. PubMed ID: 8765979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The measurement of growth hormone bioactivity in patient serum using an eluted stain assay.
    Dattani MT; Hindmarsh PC; Pringle PJ; Brook CG; Marshall NJ
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2675-83. PubMed ID: 7545696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the growth hormone releasing peptide hexarelin with somatostatin.
    Massoud AF; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1997 Nov; 47(5):537-47. PubMed ID: 9425393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion.
    Raza J; Massoud AF; Hindmarsh PC; Robinson IC; Brook CG
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):217-22. PubMed ID: 9579235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose growth hormone-releasing hormone tests: a dose-response study.
    Spoudeas HA; Winrow AP; Hindmarsh PC; Brook CG
    Eur J Endocrinol; 1994 Sep; 131(3):238-45. PubMed ID: 7921207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma GH responses to human GHRH-antagonist in normal subjects.
    Hanew K; Tanaka A; Utsumi A; Sugawara A; Abe K
    Eur J Endocrinol; 1996 Jan; 134(1):67-72. PubMed ID: 8590958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.
    Massoud AF; Hindmarsh PC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1996 May; 44(5):555-62. PubMed ID: 8762732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration.
    Wilton P; Chardet Y; Danielson K; Widlund L; Gunnarsson R
    Acta Paediatr Suppl; 1993 Mar; 388():10-5. PubMed ID: 8329825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to analogues of growth hormone-releasing hormone in normal subjects, and in growth-hormone deficient children and young adults.
    Grossman A; Savage MO; Lytras N; Preece MA; Sueiras-Diaz J; Coy DH; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Sep; 21(3):321-30. PubMed ID: 6236914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioactivity of growth hormone releasing hormone (1-29) analogues after SC injection in man.
    Aitman TJ; Rafferty B; Coy D; Lynch SS; Clayton RN
    Peptides; 1989; 10(1):1-4. PubMed ID: 2546126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.
    Aloi JA; Gertz BJ; Hartman ML; Huhn WC; Pezzoli SS; Wittreich JM; Krupa DA; Thorner MO
    J Clin Endocrinol Metab; 1994 Oct; 79(4):943-9. PubMed ID: 7962302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man.
    Arvat E; Di Vito L; Ramunni J; Gianotti L; Giordano R; Deghenghi R; Camanni F; Ghigo E
    Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.
    Chen RG; Shen YN; Yei J; Wang CF; Xie DH; Wang XH; Zhou JD; Chen CY; Wu YL; Gunnarsson R
    Acta Paediatr Suppl; 1993 Mar; 388():32-5; discussion 36. PubMed ID: 8329830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone responses to growth hormone-releasing hormone (1-29)-NH2 and a D-Ala2 analog in normal men.
    Barron JL; Coy DH; Millar RP
    Peptides; 1985; 6(3):575-7. PubMed ID: 2866496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.
    Suri D; Hindmarsh PC; Brain CE; Pringle PJ; Brook CG
    Clin Endocrinol (Oxf); 1990 Sep; 33(3):399-406. PubMed ID: 2147600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide administration, under particular temporal conditions, enhances the responses of growth hormone to growth hormone-releasing hormone in normal subjects.
    Valcavi R; Zini M
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):379-82. PubMed ID: 8187302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.
    Achermann JC; Hindmarsh PC; Robinson IC; Matthews DR; Brook CG
    Clin Endocrinol (Oxf); 1999 Nov; 51(5):575-85. PubMed ID: 10594518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.
    Horváth JE; Zarándi M; Groot K; Schally AV
    Endocrinology; 1995 Sep; 136(9):3849-55. PubMed ID: 7649091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intranasal calcitonin administration on pituitary GH response to hGHRH (1-29)NH2 in normal adult subjects.
    Giustina A; Romanelli G; Doga M; Pizzocolo G; Giustina G
    Clin Endocrinol (Oxf); 1989 Jun; 30(6):699-704. PubMed ID: 2556224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.